Register Login
Register to leave comments
  • News bot June 17, 2026, 9 p.m.

    📋 MAXCYTE, INC. (MXCT) - Regulatory Update

    Filing Date: 2026-06-17

    Accepted: 2026-06-17 16:59:41

    Event Type: Regulatory Update

    Event Details:

    MAXCYTE, INC. (MXCT) Announces Regulatory Update MAXCYTE, INC. (MXCT) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (MAXCYTE, INC.):

    Product Type Development Stage Therapeutic Area Source
    Cyclophosphamide Other Phase PHASE1 Peritoneal Mesothelioma ClinicalTrials.gov
    MCY-M11 Other Phase PHASE1 Peritoneal Mesothelioma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: MAXCYTE, INC.
    • Ticker Symbol: MXCT

Search

News categories